Evidence map›Paper›PMID 36814444›Full record

ArticleFrontiers in cellular and infection microbiology2023

Cardiomyocyte infection by

Gabriela Venturini, Juliana M Alvim, Kallyandra Padilha, Christopher N Toepfer, Joshua M Gorham, Lauren K Wasson, Diogo Biagi, Sergio Schenkman, Valdemir M Carvalho, Jessica S Salgueiro and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Research progress of connexin 43 in cardiovascular diseases.Frontiers in cardiovascular medicine · 2025
    Review
  7. The intersection of hostMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Comparative microRNA profiling ofFrontiers in cellular and infection microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Gabriela VenturiniDepartment of Genetics, Harvard Medical School, Boston, MA, United States.
Juliana M AlvimLaboratory of Genetics and Molecular Cardiology, University of São Paulo Medical School, São Paulo, Brazil.
Kallyandra PadilhaLaboratory of Genetics and Molecular Cardiology, University of São Paulo Medical School, São Paulo, Brazil.
Christopher N ToepferDepartment of Genetics, Harvard Medical School, Boston, MA, United States.
Joshua M GorhamDepartment of Genetics, Harvard Medical School, Boston, MA, United States.
Lauren K WassonDepartment of Genetics, Harvard Medical School, Boston, MA, United States.
Diogo BiagiLizarBio Therapeutics, Sao Paulo, Brazil.
Sergio SchenkmanDepartment of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, São Paulo, Brazil.
Valdemir M CarvalhoDivision of Research and Development, Fleury Group, São Paulo, SP, Brazil.
Jessica S SalgueiroDivision of Research and Development, Fleury Group, São Paulo, SP, Brazil.
Karina H M CardozoDivision of Research and Development, Fleury Group, São Paulo, SP, Brazil.
Jose E KriegerLaboratory of Genetics and Molecular Cardiology, University of São Paulo Medical School, São Paulo, Brazil.
Alexandre C PereiraDepartment of Genetics, Harvard Medical School, Boston, MA, United States.
Jonathan G SeidmanDepartment of Genetics, Harvard Medical School, Boston, MA, United States.
Christine E SeidmanDepartment of Genetics, Harvard Medical School, Boston, MA, United States.
Harvard University · USUniversidade de São Paulo · BRFleury S.A. (Brazil) · BRAssociação Paulista de Medicina · BRBrigham and Women's Hospital · US

Funding

Defining Pathways from Gene Mutation to Heart FailureR01HL080494 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI CHEN, CHRISTOPHER S, SEIDMAN, CHRISTINE E · 2005 to 2024
$9.4M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
Genetic Determinants of Chagas CardiomyopathyR01HL133165 · NHLBI · HARVARD MEDICAL SCHOOL · PI SEIDMAN, CHRISTINE E · 2017 to 2020
$1.7M
British Heart Foundation RE/18/3/34214Howard Hughes Medical InstituteNHLBI NIH HHS R01 HL080494NHLBI NIH HHS R01 HL133165NICHD NIH HHS U54 HD090255Wellcome TrustWellcome Trust 206466/Z/17/Z
6 · The paper itself

Abstract

Introduction: Chagas cardiomyopathy, a disease caused by Methods: To investigate the effects of Results: Analyses of multiomic data revealed that cardiomyocyte infection caused a rapid increase in genes and proteins related to activation innate and adaptive immune systems and pathways, including alpha and gamma interferons, HIF-1α signaling, and glycolysis. These responses resemble prototypic responses observed in pathogen-activated immune cells. Infection also caused an activation of glycolysis that was dependent on HIF-1α signaling. Using gene editing and pharmacological inhibitors, we found that Conclusion: These findings suggest that

Indexed as

Chagas CardiomyopathyChagas DiseaseTrypanosoma cruziHumansImmunity, InnateMyocytes, CardiacChagas cardiomyopathyglycolysisinflammationmetabolismTrypanosoma cruzi

Identifiers

PMID36814444
PMCPMC9940271
OpenAlexW4319297737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.